GBTA Coronavirus Statement
GBTA is a global association with operations on six continents and members throughout the world. We are very aware of the impact that the coronavirus (COVID-19) is having on the entire business travel and meetings industry.
GBTA will continue to monitor COVID-19 until the medical community says the virus has been contained. Our main concern is on the health and safety of our global members and program participants. We encourage our members to follow the travel restrictions set in place where they reside and if traveling, when they arrive at their destination. We encourage all to practice preventative measures such as those outlined by the Center for Disease Control and Prevention (CDC).
GBTA also encourages all members and attendees of our global events to check out the following resources to keep up to date with the coronavirus.
EU COVID Certificates (10th June 2021)
Following are details on how EU citizens will be able to get their COVID Certificates:
- National authorities are in charge of issuing the certificate, not the EU.
- It could, for example, be issued by test centres or national health authorities, or directly via an eHealth portal. This will vary country by country.
- Each issuing body (e.g., a hospital, a test centre, a health authority) has its own digital signature key. All of these are stored in a secure database in each country.
- The digital version can be stored on a mobile device, and citizens can also request a paper version.
- The European Commission has built a gateway through which all certificate signatures can be verified across the EU.
- The personal data of the certificate holder does not pass through the gateway, as this is not necessary to verify the digital signature.
- The European Commission also helped Member States to develop national software and apps to issue, store and verify certificates and supported them in the necessary tests to on-board the gateway.
Note that Member States have agreed on a common design that can be used for the electronic and paper versions to facilitate the recognition.
Hear from Dr. Amanda Hagen, MD, MPH, FACOEM, Medical Director with the Cleveland Clinic AtWork